Pharmaceutical Sector Growth in Bangladesh: Opportunities and Projections
E N D
Presentation Transcript
Pharmaceuticals Sector of Bangladesh • In 2014, market size was 1.46 B US$ • Per Capita consumption ~ 9.40 US$ DCCI meeting on "Bangladesh 2030 : Next Billion Dollar Opportunities"
Pharmaceutical Sector • Growth pattern (in Million US$) (12.13%) (8.12%) (11.9%) (24%) (24%) (17%) Market doubled in about 5 years DCCI meeting on "Bangladesh 2030 : Next Billion Dollar Opportunities"
Market Projection • 2015 : 1.68 B US$ • 2020 : 3.36 B US$ • 2030 : About 14 B US$ DCCI meeting on "Bangladesh 2030 : Next Billion Dollar Opportunities"
Local Production vs. Import • Local Production : 97% • Import : 3% 3% 97% Ref: Directorate General of Drugs Administration , Bangladesh DCCI meeting on "Bangladesh 2030 : Next Billion Dollar Opportunities"
Bangladesh is almost self-sufficient, many of our neighbors import significant part of their requirement. • Singapore 80% • Philippines 65% • Thailand 35% • Pakistan 30% DCCI meeting on "Bangladesh 2030 : Next Billion Dollar Opportunities"
Pharmaceutical Sector Bangladesh is capable to produce almost all types of dosage form like - • Tablet, • Capsule, • Liquid preparations, • Dry suspension, • Injections, • Ointment/cream, • Nasal spray, • Granules in sachets, DCCI meeting on "Bangladesh 2030 : Next Billion Dollar Opportunities"
Pharmaceutical Sector • Lyophilized vials, • Eye drops, • Meter Dose Inhalers, • Large volume • parenterals, • Pre-filled syringes • etc. Also, very high tech products like vaccine and Bio-similars, anti-cancer products are now produced locally. DCCI meeting on "Bangladesh 2030 : Next Billion Dollar Opportunities"
Export volume and destination • Pharmaceuticals Export : $ 59.17 Million • July – April (2014-2015) • Expected yearly export : $ 71.00 Million • (2014-2015) Source: EPB DCCI meeting on "Bangladesh 2030 : Next Billion Dollar Opportunities"
Export from Bangladesh 88 countries - • Asia incl. Middle East & Pacific Island • Mayanmar Pakistan Hong Kong • Singapore Vietnam Philippine • Sri Lanka Cambodia Nepal • Indonesia Malaysia UAE • Jordan Yemen Papua Newguinea • Fiji Saudi Arabia Solomon Island • Tajikistan Thailand Afghanistan • Bhutan India Japan • Korea Macau Mongolia • Samoa Guam Tonga • Kiribati Azerbaijan Maldives • Europe • UK Spain Switzerland • Ukraine Turkey Denmark • Belgium Slovenia Austria • Germany Italy Netherland • Poland Portugal Armenia • Russia Hungary • Latin & Central America • Brazil Venezuela Belize • Nicaragua Honduras Guatemala • Mexico Colombia Guyana • Chile Costa Rica Panama • Republica Dominica • Africa • South Africa Kenya Ghana Mauritius • Somalia Togo Gambia Nigeria • Ethiopia SudanBarkinafaso Tanzania • Botswana Egypt Libya Morocco • Seychelles Tunisia Swaziland Chad • Liberia Australia & New Zealand USA Ref: DGDA
Factors for Pharma sector development • A viable local market • Human Resources • Pharmacists - (1500) • Chemists - (3000) • Microbiologists - (200) • Doctors - (5000) • Engineers - (5000) DCCI meeting on "Bangladesh 2030 : Next Billion Dollar Opportunities"
Regional Opportunity Bangladesh is in the middle of regions with population of 2.2 Billion and Billions of USD market. Just imagine the possibilities.
Why Bangladesh? • Local market opportunity • In the middle of a vibrant emerging market • Highly skilled Human Resource • API industrial park • Future medicines (50%) are likely to be biologicals • India +1 country for supply of generics at competitive prices DCCI meeting on "Bangladesh 2030 : Next Billion Dollar Opportunities"